Marcus Antonius Van Dijk Mi Nk Therapeutics, Inc. (INKT) insider trading activity
Marcus Antonius Van Dijk is Chief Scientific Officer of MiNK Therapeutics, Inc.. Currently has a direct ownership of 27,363 shares of INKT, which is worth approximately $19,701. The most recent transaction as insider was on Jan 09, 2023, when has been sold 24,265 shares (Common Stock) at a price of $2.32 per share, resulting in proceeds of $56,294. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
27.4K
0%
3M change
0%
12M change
Total Value Held
$19,701
Marcus Antonius van Dijk Transaction History
MAv
Marcus Antonius Van Dijk
Chief Scientific Officer
New York, NY